Are weight loss drugs the answer to obesity?

This podcast episode examines the global obesity problem and the role of weight loss drugs, particularly Ozempic and Wegovy, in addressing it. The discussion also explores the challenges of accessing and affording these medications, as well as the complexities faced by manufacturers in meeting the unprecedented demand. It delves into other weight loss drugs, their mechanisms of action, and their long-term implications. The episode emphasizes the need for comprehensive approaches to combat obesity and the importance of responsible use and regulation of weight loss medications.